Iqvia shares drop 5% after FDA finds errors in its opioid sales data, calls for quality review

The error led to an overestimation of the amount of prescription fentanyl being used in the U.S.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>